Microfluidic chip enables single-cell measurement for multidrug resistance in triple-negative breast cancer cells

Aims: Triple-negative breast cancer patients are commonly treated with combination chemotherapy. Nonetheless, outcomes remain substandard with relapses being of a frequent occurrence. Among the several mechanisms that result in treatment failure, multidrug resistance, which is mediated by ATP-bindin...

Descripción completa

Detalles Bibliográficos
Autores principales: Parekh, Karan, Noghabi, Hamideh Sharifi, Lopez, Jose Alejandro, Li, Paul Chi Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992477/
https://www.ncbi.nlm.nih.gov/pubmed/35582454
http://dx.doi.org/10.20517/cdr.2019.77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992477/
https://www.ncbi.nlm.nih.gov/pubmed/35582454
http://dx.doi.org/10.20517/cdr.2019.77

Ejemplares similares